跳至主要内容
临床试验/NCT02569775
NCT02569775已完成2 期

Outcomes of Autologous Bone Marrow Mononuclear Cells for Cerebral Palsy: A Self-Controlled Clinical Trial

Vinmec Healthcare System1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2014年4月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
40
试验地点
1
主要终点
Change in Gross Motor Function Measure (GMFM)-66 Percentile

研究概览

简要总结

The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in patients with cerebral palsy.

详细描述

The aim of this study is to assess the safety and effectiveness of autologous bone marrow mononuclear stem cells in 40 patients with cerebral palsy at Vinmec International Hospital, Hanoi, Vietnam.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
1 Year 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Cerebral palsy of any types caused by oxygen deprivation.

排除标准

  • Hydrocephalus with ventricular drain
  • Coagulation disorders
  • Allergy to anesthetic agents
  • Severe health conditions such as cancer, failure of heart, lung, liver or kidney
  • Active infections

结局指标

主要结局

Change in Gross Motor Function Measure (GMFM)-66 Percentile

时间窗: 3 months and 6 months after transplantation

GMFM-66 percentile

Change in Total Score of Gross Motor Function Measure (GMFM)-88

时间窗: 3 months and 6 months after transplantation

GMFM-88

次要结局

  • Change in Muscle tone(3 months and 6 months after transplantation)
  • Number of adverse events(Through study completion, an average of 6 months)

研究者

发起方
Vinmec Healthcare System
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验